Tyra Biosciences, Inc. · NASDAQ:TYRA
Fuhrman Alan received 951 Tyra Biosciences, Inc. shares as an award (Form 4)
Traded Sep 15, 2026 · Filed Sep 17, 2026
On Sep 15, 2026, Fuhrman Alan (Chief Financial Officer) received 951 Tyra Biosciences, Inc. shares as an award at US$9.13 for US$8,683, leaving 37,115 shares. Filed Sep 17, 2026 (Form 4).
- Awarded
- 951 shares
- Price
- US$9.13
- Value
- US$8,683
- Holding after
- 37,115 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | Award | 951 | US$9.13 | 37,115 | Direct |
Source
Related
- Tyra Biosciences, Inc.
- Fuhrman Alan
- Tyra Biosciences, Inc. shareholders
- Form 4 · Fuhrman Alan · May 7, 2026
- Schedule 13G · Bvf Partners L P · Sep 21, 2026
- Form 4 · Harris Todd · Sep 17, 2026
- Form 4 · Rueb Yuliya · Sep 17, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Sep 17, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Sep 17, 2026